A Phase 4 interventional study of Hibiclens and Isopropyl Alcohol 70% Topical Application Solution in Microbial Colonization and Foot and Ankle Disorders, sponsored by University of Missouri-Columbia. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-27.
Sponsored by University of Missouri-Columbia · Phase 4, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 161 studies in Communicable Diseases with a site in United States — 29 open to participants now, 43 under way, none of them phase 3. Communicable Diseases · United States.
Among the 161 studies in Communicable Diseases with a site in United States, this one is the 51st largest by planned enrollment of the 115 interventional ones that give a count, is one of 12 that started in 2022, is one of 6 in phase 4, reaches primary completion later than 17 of the 40 other live ones, and was the 119th registered.
628 studies on the registry are indexed under Communicable Diseases; 129 are open to participants now.
Browse Communicable Diseases studies →29 of the 161 studies in Communicable Diseases with a site in United States are open now. Recruiting first, the newest first:
AusperBio Therapeutics Inc. · Sites in United States, Canada, France and 3 more countries
Ages 18–65
Mayo Clinic · Sites in United States
Ages 18+
Vanderbilt University Medical Center · Sites in United States
Ages 18+
Johns Hopkins University · Sites in United States
Ages 0–60 · Healthy volunteers
University of Minnesota · Sites in United States, Argentina, Australia and 18 more countries
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 91 Communicable Diseases studies recruiting now, 49 (54%) set no upper age limit and 32 (35%) stop at 75 or younger; 35 take children under 18; 40 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
161 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 20 · Phase 2 22 · Phase 3 12 · Phase 4 6
First in 1991; this study’s year is marked. 12 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 89 across 381 interventional studies indexed under Communicable Diseases.
Median enrollment 78 across the 115 interventional studies, 350 across the 44 observational. Of the 105 that completed or were terminated, 29 (28%) have results posted.
This tab as a report to print or save as PDF → With an account.
32 of 161 have an industry lead sponsor. The 10 most frequent:
University of Missouri-Columbia is the lead sponsor of 365 studies on the registry; 69 are open to participants now.
Of its 43 completed or terminated interventional studies of FDA-regulated products, 29 (67%) have results posted.
University of Missouri-Columbia has 3 studies filed under Communicable Diseases — fewer than ten, so there is no comparison to draw.
12 of the studies in Communicable Diseases with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04796285Brigham and Women's HospitalA Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor | 2026-12 |
| NCT05401292University of Missouri-ColumbiaSkin Preparation for Elective Foot and Ankle Surgery | 2026-12 |
| NCT07043712University of Missouri-ColumbiaEffects of Pulse Consumption, Gut Microbiome, and Appetite in Healthy Participants | 2026-12-31 |
| NCT07287332Mayo ClinicBLOOM: Pragmatic Feasibility Trial | 2027-03 |
| NCT06546020Montana State UniversityGut Microbiota-dependent Health Impacts of Haskap Berries | 2027-05 |
Add all 12 to your calendar (.ics) → With an account.
Among the 161 studies in Communicable Diseases with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Surgical site infections (SSIs) make about 31% of all nosocomial infections and they are the most common hospital-acquired infection. For foot and ankle elective interventions, SSI rate is reported between 0.4% and 3.6%. This study will investigate the effectiveness of skin cleaning with isopropyl alcohol and scrubbing with chlorhexidine soap before standard skin preparation in reducing microbial load and surgical site infections for elective foot and ankle surgeries. Current standard of care includes skin preparation with iodine or chlorhexidine solution prior to sterile draping and the start of surgery. Standard of care will be applied to all patients. The use of an additional "pre-scrub" with isopropyl alcohol and scrubbing with chlorhexidine soap will be applied to the experimental group. The control group will receive only the standard of care skin preparation with iodine or chlorhexidine solution prior to draping.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Standard of care with only skin preparation of iodine or chlorhexidine solution prior to sterile draping before surgery.
Drug: Hibiclens
In addition to standard of care skin preparation with iodine or chlorhexidine solution prior to sterile draping, patients will also receive an additional "pre-scrub" with isopropyl alcohol and chlorhexidine soap. The operative extremity will be scrubbed for 2 minutes with chlorhexidine soap with a scrub brush until the entire extremity is covered. Isopropyl alcohol will then be wiped onto the skin with a gauze and allowed to evaporate (dry).
Drug: Hibiclens · Drug: Isopropyl Alcohol 70% Topical Application Solution
antiseptic/antimicrobial skin cleanser for skin wound and general skin cleansing
First aid antiseptic
Surgical Site Infection
rate of surgical site infection (SSI) and wound complications following skin preparation for surgery. Measured by the number of surgical site infections in the total population of patients in the cohort
Time frame: 90 days
Microbial Load
effectiveness of reducing microbial load. Comparing original microbial load to final microbial load (CFU/g)
Time frame: 90 days
Plan to share: Undecided
No publications or documents are linked to this record.
Started Feb 2022 (actual). Primary completion is estimated for Dec 2026, 58 months after the start.
Of 13 phase 4 interventional studies under Communicable Diseases, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 65. This study's planned 58 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: 2-Propanol
University of Missouri-Columbia →